$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Fatty acid treatment 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/20
  • A61K-009/48
출원번호 US-0106989 (1993-08-16)
우선권정보 GB-0017780 (1992-08-21)
발명자 / 주소
  • Horrobin David F. (Guildford GB2) Reynolds Brenda E. (Guildford GB2)
출원인 / 주소
  • Scotia Holdings PLC (GBX 03)
인용정보 피인용 횟수 : 89  인용 특허 : 1

초록

Increasing gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptabe form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in treatment of osteoporosis.

대표청구항 ▼

A method for increasing gut calcium absorption in humans or animal comprising administering a calcium salt of gamma-linolenic acid (GLA), dihomo-gamma-linolenic add (DGLA) or linoleic acid (LA), optionally in association with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or other essential

이 특허에 인용된 특허 (1)

  1. Horrobin David F. (c/o Efamol Limited ; Egamol House ; Woodbridge Meadows Guildford ; Surrey GB2 GU1 1BA) Huang Y. Sheng (c/o Efamol Research Inc. ; Annapolis Valley Industrial Park ; P.O. Box 818 ; , Therapeutic composition and method.
    상세보기

이 특허를 인용한 특허 (89)

  1. Shinohara, Gou; Tsuchiya, Kin ya; Yamanouchi, Katsuaki; Inui, Toshiyuki, Agent for improving bone metabolism.
    상세보기
  2. Strohmaier,George K.; Luchini,Nestor D.; Varcho,Michael A.; Frederiksen,Eiler D., Calcium salt saponification of polyunsaturated oils.
    상세보기
  3. Gleason, John; Jost, Douglas; Merrell, Philip H.; Caskey, Doug, Co-precipitated salts of fatty acids.
    상세보기
  4. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject.
    상세보기
  5. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides.
    상세보기
  6. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
    상세보기
  7. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy.
    상세보기
  8. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
    상세보기
  9. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
    상세보기
  10. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
    상세보기
  11. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
    상세보기
  12. Zakrzewski, Joseph S., Compositions and methods for treating or preventing obesity in a subject in need thereof.
    상세보기
  13. Zakrzewski, Joseph S., Compositions comprising EPA and obeticholic acid and methods of use thereof.
    상세보기
  14. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
    상세보기
  15. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof.
    상세보기
  16. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
    상세보기
  17. Zakrzewski, Joseph S., Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof.
    상세보기
  18. Chilton, Floyd; Lu, Fan, Compositions, methods, and kits for polyunsaturated fatty acids from microalgae.
    상세보기
  19. Levinson, R. Saul; Hermelin, Marc S.; Kirschner, Mitchell I., Formulation for menopausal women.
    상세보기
  20. Peet, Malcolm; Vaddadi, Krishna S., Highly purified ethyl EPA and other EPA derivatives.
    상세보기
  21. Peskin, Brian, Medicament for treatment of cancer, cardiovascular diseases and inflammation.
    상세보기
  22. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
    상세보기
  23. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
    상세보기
  24. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Zakrzewski, Joseph S., Methods of reducing apolipoprotein C-III.
    상세보기
  25. Mason, Richard Preston, Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids.
    상세보기
  26. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  27. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  28. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  29. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  30. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  31. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  32. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  33. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  34. Soni, Paresh, Methods of reducing the risk of a cardiovascular event in a subject on statin therapy.
    상세보기
  35. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  36. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  37. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  38. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  39. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  40. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  41. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  42. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  43. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  44. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  45. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  46. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  47. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  48. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  49. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  50. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Breackman, Rene; Soni, Paresh, Methods of treating hypertriglyceridemia.
    상세보기
  51. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
    상세보기
  52. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
    상세보기
  53. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
    상세보기
  54. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
    상세보기
  55. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Methods of treating mixed dyslipidemia.
    상세보기
  56. Horrobin David F,GBX ; Knowles Philip,GBX ; Manku Mehar S,GBX, Methods of treatment using ascorbyl gamma linolenic acid or ascorbyl dihomo-gamma-linolenic acid.
    상세보기
  57. Manku, Mehar; Climax, John; Coughlan, David, Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof.
    상세보기
  58. Manku, Mehar; Climax, John; Coughlan, David; Dunne, James, Pharmaceutical compositions comprising DGLA and use of same.
    상세보기
  59. Manku, Mehar; Climax, John; Coughlan, David, Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof.
    상세보기
  60. Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Pharmaceutical compositions comprising fatty acids.
    상세보기
  61. Barnwell, Stephen George; Higginbottom, Simon; Whelan, Ian Peter; Burns, Stephen John, Pharmaceutical formulations.
    상세보기
  62. Luchini, Daniel Nestor; Strohmaier, George K.; Frederiksen, Eiler D.; Hawkes, James G.; Dull, Bob J., Polyunsaturated fatty acid monovalent and divalent metal salt synthesis.
    상세보기
  63. Manku, Mehar, Stable pharmaceutical composition and methods of using same.
    상세보기
  64. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  65. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  66. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  67. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  68. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  69. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  70. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  71. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  72. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  73. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  74. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  75. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  76. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  77. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  78. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  79. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  80. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  81. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  82. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  83. Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Stable pharmaceutical composition and methods of using same.
    상세보기
  84. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Topical compositions comprising polyunsaturated fatty acids.
    상세보기
  85. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Topical compositions comprising polyunsaturated fatty acids.
    상세보기
  86. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Use of PUFAS for treating skin inflammation.
    상세보기
  87. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Use of PUFAs for treating skin inflammation.
    상세보기
  88. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Use of pufas for treating skin inflammation.
    상세보기
  89. Kelliher, Adam; Morrison, Angus; Knowles, Phil, Use of pufas for treating skin inflammation.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로